12 West Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-350,000
Closed -$8.8M 15
2018
Q4
$8.8M Sell
350,000
-159,191
-31% -$4.09M 0.91% 13
2018
Q3
$14.7M Sell
509,191
-640,809
-56% -$12M 1.08% 16
2018
Q2
$14.1M Buy
+1,150,000
New +$13.2M 1.16% 17

Other funds holding CDNA

12 West Capital Management's CDNA Position: Q1 2019 in Review

12 West Capital Management sold out of CareDx (CDNA) in Q1 2019, closing a stake of 350,000 shares — an estimated $8.8M sold.

12 West Capital Management first reported a position in CDNA in Q2 2018 and held it in 3 quarters. The position peaked at $14.7M in Q3 2018. 182 funds tracked by Wall St. Rank hold CDNA as of Q1 2019.

  • 12 West Capital Management reported no remaining CareDx position as of Q1 2019 after selling out during the quarter.
  • 12 West Capital Management sold 350,000 CareDx shares in Q1 2019, an estimated $8.8M.
  • 12 West Capital Management first reported a position in CareDx in Q2 2018 and held it in 3 quarters.
  • 12 West Capital Management's CareDx position peaked at $14.7M in Q3 2018.
  • 182 funds tracked by Wall St. Rank held CareDx as of Q1 2019.

Based on 12 West Capital Management's 13F filing for Q1 2019, filed 15 May 2019.